StockGlow

BridgeBio Pharma, Inc. (2CL.F)

BridgeBio Pharma, Inc., a biopharmaceutical company, discovers, develops, and delivers medicines for patients with genetic diseases.

69.45+0.00%Healthcare
Compare 2CL.F with
StockGlow Score
88
Bullish
BearishBullish
1 year ago+73.5%

The outlook

BridgeBio Pharma, Inc. currently reads as bullish based on above its 50- & 200-day averages, 80% of the way from its 52-week low to high. This is a snapshot of current market data, not a forecast.

What’s behind the score

Price trendAbove its 50- & 200-day averages
52-week range80% of the way from its 52-week low to high
Market cap
$13.60B
52-wk high
77.81
52-wk low
36.06
50-day avg
63.53
200-day avg
61.41
Trailing P/E
—

Similar stocks

2L9.FVisionWave Holdings, Inc.$1.63-4.13%RV7.FHalozyme Therapeutics, Inc.$72.16-0.39%ISI.FIonis Pharmaceuticals, Inc.$46.26-0.64%KK3A.FCytokinetics, Incorporated$69.26-1.34%HDP1.FArrowhead Pharmaceuticals, Inc.$74.82-1.03%

The StockGlow Score is a snapshot of current, observable market data (analyst ratings, price trend, 52-week range) — not a prediction, forecast, or recommendation. Informational only, not investment advice. Data from public sources and may be delayed. How this works·Privacy